I'm Joe Graydon. And I'm Terry Graydon. Welcome to this podcast of the People's Pharmacy.

You can find previous podcasts and more information on a range of health topics at people's pharmacy.com.

Dizziness and vertigo are both common and complicated. They can be hard to diagnose and challenging to cure.

This is the People's Pharmacy with Terry and Joe Graydon.

One of the lingering complications of long COVID has been postural orthostatic tachycardia syndrome, known as Potts.

People often feel lightheaded or dizzy when they stand up.

Many other conditions can also upset your balance.

Low blood pressure, many different medications, ear infections, or migraines can all trigger vertigo.

How can doctors accurately differentiate between these and many other possible causes of balance problems?

Our guest will answer your questions.

Coming up on the people's pharmacy, overcoming vertigo and dizziness.

In the People's Pharmacy Health Headlines, drugs used for diabetes and weight loss seem to have other benefits as well.

The GLP1 agonists like Samaglutide have shown some promise against addictions, like alcohol use disorder, as well as cardiovascular benefits.

Now a study in JAMA neurology suggests that people taking drugs like Ozampic or Wigovi may reduce their risk of developing Alzheimer disease or similar dementias.

Other diabetes drugs like Ampagliflozin or Jardians or Diplaflozine, Farciga, appear to offer

protection as well. Researchers analyzed health records of Luritians over 50 between 2014 and

2023. The relative risk reduction was impressive,

calculated at 33 to 43 percent. The absolute risk reduction, as usual, is less dramatic.

2.26 fewer individuals on samaglutide developed dementia over a thousand person years. The rate

for the flosins was about three fewer per thousand person years. Rather than placebo, other diabetes

drugs provided the comparison. The authors note that these findings might encourage doctors to

consider one of these medications for people with type 2 diabetes

...